Tao Fu

2017

In 2017, Tao Fu earned a total compensation of $2.4M as Executive Vice President, Chief Commercial and Business Officer at Portola Pharmaceuticals, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$222,381
Option Awards$959,013
Salary$411,817
Stock Awards$798,125
Other$8,100
Total$2,399,436

Fu received $959K in option awards, accounting for 40% of the total pay in 2017.

Fu also received $222.4K in non-equity incentive plan, $411.8K in salary, $798.1K in stock awards and $8.1K in other compensation.

Rankings

In 2017, Tao Fu's compensation ranked 4,644th out of 14,666 executives tracked by ExecPay. In other words, Fu earned more than 68.3% of executives.

ClassificationRankingPercentile
All
4,644
out of 14,666
68th
Division
Manufacturing
1,634
out of 5,772
72nd
Major group
Chemicals And Allied Products
475
out of 2,075
77th
Industry group
Drugs
367
out of 1,731
79th
Industry
Pharmaceutical Preparations
290
out of 1,333
78th
Source: SEC filing on April 24, 2018.

Fu's colleagues

We found four more compensation records of executives who worked with Tao Fu at Portola Pharmaceuticals in 2017.

2017

William Lis

Portola Pharmaceuticals

Chief Executive Officer

2017

John Lawrence

Portola Pharmaceuticals

Chief Medical Officer

2017

Mardi Dier

Portola Pharmaceuticals

Chief Financial Officer

2017

John Curnutte

Portola Pharmaceuticals

Executive Vice President, Research and Development

You may also like